Schonfeld Strategic Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-27,139
| Closed | -$231K | – | 2209 |
|
|
2024
Q2 | $231K | Buy |
+27,139
| New | +$231K | ﹤0.01% | 1633 |
|
|
2024
Q1 | – | Sell |
-16,500
| Closed | -$90.4K | – | 2171 |
|
|
2023
Q4 | $90.4K | Buy |
+16,500
| New | +$90.4K | ﹤0.01% | 1542 |
|
|
2022
Q4 | – | Sell |
-11,600
| Closed | -$62K | – | 2867 |
|
|
2022
Q3 | $62K | Sell |
11,600
-8,800
| -43% | -$47K | ﹤0.01% | 2554 |
|
|
2022
Q2 | $86K | Sell |
20,400
-8,100
| -28% | -$34.1K | ﹤0.01% | 2089 |
|
|
2022
Q1 | $100K | Buy |
+28,500
| New | +$100K | ﹤0.01% | 2167 |
|